Anika Therapeutics (ANIK) Inventory (2010 - 2026)

Anika Therapeutics (ANIK) has 17 years of Inventory data on file, last reported at $22.8 million in Q1 2026.

• Inventory for Q1 2026 came in at $22.8 million, up 7.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.8 million (up 7.04% YoY), and the FY2025 annual result was $18.8 million, down 21.09% from the prior year.
• Inventory climbed to $22.8 million in Q1 2026 per ANIK's latest filing, from $18.8 million in the prior quarter.
• Over five years, Inventory peaked at $51.5 million in Q2 2024 and troughed at $16.3 million in Q3 2025.
• A 5-year average of $32.9 million and a median of $35.3 million in 2022 frame the typical range for Inventory.
• The sharpest annual moves came in 2024 and 2025: Inventory rose 20.8% in 2024, then plunged 67.12% in 2025.
• A 5-year view of Inventory shows it stood at $39.8 million in 2022, then sank by 38.57% to $24.4 million in 2023, then retreated by 2.53% to $23.8 million in 2024, then dropped by 21.09% to $18.8 million in 2025, then rose by 21.56% to $22.8 million in 2026.
• Business Quant data shows ANIK's Inventory at $22.8 million in Q1 2026, $18.8 million in Q4 2025, and $16.3 million in Q3 2025.